Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
International Journal of Cancer|March 25, 2006
Tumor iNOS predicts poor survival for stage III melanoma patientsSuhendan Ekmekcioglu, Julie A Ellerhorst, Victor G Prieto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancerXifeng Wu, Hua Zhao, Kim-Anh Do, et al.Carcinogenesis|February 8, 2005
N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cellsAnn-Marie Simeone, Chu-Xia Deng, Gary J Kelloff, et al.American Journal of Clinical Oncology|June 7, 2007
Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overloadSukesh C Burjonroppa, Ann T Tong, Lian-Chun Xiao, et al.Journal of Cutaneous Pathology|February 19, 2009
Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survivalFredrik Petersson, A Hafeez Diwan, Doina Ivan, et al.Medicine|March 18, 2016
Elevated Serum Leptin Levels are Associated With an Increased Risk of Sentinel Lymph Node Metastasis in Cutaneous MelanomaJunna Oba, Wei Wei, Jeffrey E Gershenwald, et al.The American Journal of Dermatopathology|November 14, 2012
Differential expression of the G-protein-coupled formyl Peptide receptor in melanoma associates with aggressive phenotypeNitin Chakravarti, Vijay G R Peddareddigari, Carla L Warneke, et al.Journal of Immunotoxicology|June 24, 2008
Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survivalAgop Y Bedikian, Marcella M Johnson, Carla L Warneke, et al.BJU International|August 2, 2006
Suburethral sling at the time of radical prostatectomy in patients at high risk of postoperative incontinenceO Lenaine Westney, Shellie Scott, Christopher Wood, et al.Breast Cancer Research : BCR|May 14, 2008
TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cellsAnn-Marie Simeone, Vanity McMurtry, René Nieves-Alicea, et al.Pageof 6